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yrosine kinase growth factor receptor signaling in-
ﬂuences proliferation, survival, and apoptosis. Hair
follicles undergo cycles of proliferation and apop-
totic regression, offering an excellent paradigm to study
how this transition is governed. Several factors are
known to affect the hair cycle, but it remains a mystery
whether Akt kinases that are downstream of growth fac-
tor signaling impact this equilibrium. We now show that
an Akt relative, Sgk (serum and glucocorticoid responsive
kinase) 3, plays a critical role in this process. Hair folli-
T
 
cles of mice lacking Sgk3 fail to mature normally. Prolifer-
ation is reduced, apoptosis is increased, and follicles pre-
maturely regress. Maintenance of the pool of transiently
amplifying matrix cells is impaired. Intriguingly, loss of
Sgk3 resembles the gain of function of epidermal growth
factor signaling. Using cultured primary keratinocytes,
we ﬁnd that Sgk3 functions by negatively regulating
phosphatidylinositol 3 kinase signaling. Our results re-
veal a novel and important function for Sgk3 in control-
ling life and death in the hair follicle.
 
Introduction
 
Tissue homeostasis relies on a delicate balance of proliferation
and apoptosis. Understanding the molecular mechanisms that
are involved is a prerequisite for learning how the process goes
awry in disease states, including cancers as well as autoim-
mune and inflammatory disorders. The murine hair follicle is a
dynamic model of coordinated cell division, differentiation,
and cell death that provides an effective platform for investi-
gating the regulation of proliferation and apoptosis.
During embryonic hair follicle development, mesenchy-
mal condensates assemble beneath the epidermis and induce
downward epithelial remodeling and proliferation to form a
hair bud (Schmidt-Ullrich and Paus, 2005). As the follicle de-
velops, daughter cells within the central core begin to exit the
cell cycle and differentiate to generate the hair shaft and its sur-
rounding channel, the inner root sheath (IRS). By the time the
follicle reaches maturity shortly after birth, it has established a
remarkably productive hair factory, called the bulb, that con-
tains transiently proliferative epithelial (matrix) cells surround-
ing specialized mesenchymal cells (dermal papilla [DP]) at the
base. The matrix cells differentiate upward into six lineage-dis-
tinct, concentric cellular layers of the hair shaft and IRS.
After the growth phase, the follicle suddenly undergoes a
catastrophic arrest, during which time the lower two thirds re-
cedes; some cells terminally differentiate, and others undergo
apoptosis (Muller-Rover et al., 2001). As the residual strand of
epithelial cells shrinks, the mature mesenchymal condensate
(DP) is dragged upward until it comes to rest below the perma-
nent epithelial portion of the follicle. The mesenchymal–epi-
thelial interaction stimulates activation of stem cells, and a new
hair growth cycle begins (Taylor et al., 2000; Blanpain et al.,
2004; Morris et al., 2004). Cycles of growth (anagen), regres-
sion (catagen), and rest (telogen) continue throughout the life-
time of all mammalian hair follicles. Despite the temporally
discrete phases of proliferation and apoptosis in the hair folli-
cle, little is known about the signals that maintain proliferation
and/or cell survival during anagen, and even less is known
about how these signals are balanced against those that pro-
mote catagen.
Numerous studies encompassing many different eukary-
otic systems underscore the importance of tyrosine kinase
growth factor receptor signaling pathways in regulating prolif-
eration, survival, differentiation and apoptosis (for review see
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Holbro et al., 2003). The outcome of growth factor signaling is
dependent on the cell type, the signal received, and the recep-
tor. In the anagen hair follicle, multiple growth factors for
tyrosine kinase receptors are present, including insulin-like
growth factors (IGFs), EGF, FGFs, and PDGF (Stenn and
Paus, 2001). Genetic analyses of these factors in mice have un-
covered a surprising variety of hair defects ranging from the
promotion of follicle morphogenesis (Liu et al., 1993) and dif-
ferentiation of the hair shaft (Guo et al., 1996) to the induction
of catagen (Sundberg et al., 1997) and maintenance of the sup-
portive dermis (Karlsson et al., 1999). The two principle sig-
naling routes that are activated by growth factor receptor ty-
rosine kinases are the Ras–Raf–MEK (MAPK/extracellular
regulated kinase [ERK] kinase)–MAPK (Johnson and Lapadat,
2002) and phosphatidylinositol 3 kinase
 
 
 
(PI3K)–PDK1–Akt
pathways (Datta et al., 1999). 
 
Akt1
 
-null mice exhibit retarda-
tion of postnatal hair follicle morphogenesis (Di-Poi et al.,
2005), and mice that are double null for 
 
Akt1
 
 and 
 
Akt2
 
 die
shortly after birth and exhibit pleotropic defects, including im-
paired skin and hair follicle development (Peng et al., 2003).
However, the roles for these or other downstream pathway
members in regulating the choice between proliferation and
apoptosis in anagen hair follicles have remained elusive.
The serum and glucocorticoid responsive kinase (Sgk)
family consists of three serine-threonine kinases that share a
highly similar kinase domain with Akt family members, but
their lack of a plasma membrane–targeting
 
 
 
(pleckstrin homol-
ogy) domain suggests possible nonoverlapping functions (for
review see Lang and Cohen, 2001; Firestone et al., 2003). Sgk3
(also known as cytokine-independent cell survival kinase) is
particularly interesting because it contains a Phox domain (first
identified on phagocyte oxidase proteins), which prefers phos-
phatidylinositides that target the kinase to the early endosome
rather than to the plasma membrane (Virbasius et al., 2001; Xu
et al., 2001). Like conventional Akts, Sgk3 can be activated by
IGF-1 and EGF in a manner that is dependent on tyrosine ki-
nase receptor activation of PI3K (Kobayashi and Cohen, 1999;
Kobayashi et al., 1999; Virbasius et al., 2001). Additionally,
overexpression of Sgk3 protects against apoptosis in hemato-
logic cells that have been deprived of IL-3 (Liu et al., 2000).
On the basis of these findings, Sgk3 has been surmised to act as
a cell survival kinase with properties similar to that of Akt.
Recently, it was reported that 
 
Sgk3
 
-null mice display a
hair coat defect, which was attributed to aberrations in Wnt
signaling, altered proliferation, an absence of apoptosis, and a
delayed onset of catagen (McCormick et al., 2004). Indepen-
dently, we targeted 
 
Sgk3
 
 for ablation, but in analyzing the
mice, we have come to a different conclusion as to the pheno-
typic consequences and underlying molecular basis of the de-
fects involved. Although the loss of 
 
Sgk3
 
 results in reduced
proliferation, it is actually accompanied not by delayed but
rather by premature entry into catagen. Our studies reveal a re-
quirement for Sgk3 in regulating the maintenance of the tran-
sit-amplifying matrix cell population that supplies the anagen
bulb. By evaluating growth factor signaling in primary kerati-
nocytes that were cultured from 
 
Sgk3
 
-null mice, we discovered
that keratinocytes lacking Sgk3 exhibit a paradoxically in-
creased responsiveness to IGF-1, suggesting the existence of a
novel feedback pathway in which Sgk3 acts to inhibit PI3K
pathway activation. Our results provide the first documentation
for a role of an Sgk/Akt kinase in governing the balance be-
tween the growing and destructive phases of the hair cycle.
 
Results
 
Mice lacking Sgk3 are viable and fertile
 
To determine the physiological role of Sgk3, we used homolo-
gous recombination in embryonic stem (ES) cells to generate
 
Sgk3
 
 knockout (KO) mice. The targeting vector was designed
to remove two critical exons of the Sgk3 kinase domain contain-
ing the catalytic core, including a lysine residue that is essential
for ATP binding; stop codons were inserted just downstream of
the exon 8 splice acceptor site (Fig. 1 A). Three independent
clones (
 
Sgk3
 
-4, -17, and -44) carrying the mutated 
 
Sgk3
 
 allele
were used for further analysis. F
 
1
 
 heterozygotes originating
from 
 
Sgk3
 
-17 or -44 clones were intercrossed to produce ho-
mozygous F
 
2
 
 progeny. Of 120 F
 
2
 
 pups, 35 were 
 
 
 
/
 
 
 
 (29%), 54
were 
 
 
 
/
 
 
 
 (45%), and 31 were 
 
 
 
/
 
 
 
 (26%), which is consistent
with the expected Mendelian ratio. Southern blot hybridization
of DNA from F
 
2
 
 offspring demonstrated a presence of the tar-
geted allele (Fig. 1 B). Northern blot analysis was consistent
with a marked reduction of 
 
Sgk3
 
 transcripts in 
 
 
 
/
 
 
 
 skin (Fig.
1 C). Western blot analysis of lysates that were probed with an
antibody against the Phox domain confirmed the presence of
Sgk3 protein in keratinocytes that were cultured from the skins
of newborn 
 
 
 
/
 
 
 
 and 
 
 
 
/
 
 
 
 mice and confirmed the loss of
Sgk3 protein in 
 
 
 
/
 
 
 
 mice (Fig. 1 D). Western analysis of skin
fractions demonstrated that Sgk3 is present in the hair follicle
fraction and is absent from the epidermal fraction at postnatal
day (P) 5 (Fig. 1 E). This is consistent with the prior report that
Sgk3 mRNA is expressed in the hair follicle root sheaths and
matrix but not in interfollicular epidermis (McCormick et al.,
2004). Western blot analysis detected Sgk3 protein throughout
the synchronous progression of hair follicles from anagen
through catagen and telogen (Fig. 1 E).
 
Mice lacking Sgk3 have an abnormal
hair coat
 
Mice homozygous for the 
 
Sgk3
 
-null allele (KO) were healthy
and of normal size and weight. However, their whiskers and
hair coats were distinctly abnormal (Fig. 2, A–M). Other epi-
dermal-derived structures seemed normal; mammary gland
function was intact, as KO females nursed pups to weaning
without difficulty, sweat glands functioned properly as deter-
mined by an iodine sweat test (unpublished data), sebaceous
glands produced sebum as determined by an oil red O stain of
postnatal and adult back skin (unpublished data), and teeth ap-
peared fully functional.
Newborn 
 
Sgk3
 
-null pups were identifiable by their whis-
kers, which bent erratically and often pointed forward or out-
ward, lacking the organized straightness of normal whisker sets
(Fig. 2, G and H). Throughout life, their hair coat was sparse and
their epidermis was visible through the coat (Fig. 2, A–D). The
hair shafts themselves were malformed. In contrast to the normal 
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coat, which consists of straight (guards and awls) and kinked
hairs (zigzags), 
 
Sgk3
 
-null hairs lacked straight segments or orga-
nized kinks and, instead, curled and bent randomly (Fig. 2, E, F,
I, and J). Scanning EM revealed that 
 
Sgk3
 
-null hairs were atypi-
cally thin, displaying thickened knobby regions and thin spindly
regions (Fig. 2, K and L). The cuticle cells that provide a shingle-
like surface to the hair shaft were present in KO hairs, although
they were often poorly adherent to the shaft. Quantitative analy-
sis revealed that the majority of KO hairs were unusually short,
with the exception of guard hairs, which constitute a relatively
minor portion of the overall hair coat (Fig. 2 M). Histological
analyses of P36 and P411 skins showed no difference in overall
follicle density (Fig. 2, N–Q, arrows). Transmission EM indi-
cated that all the morphologically distinct cell types were present
in KO follicles, including the three IRS layers; keratinization of
Henley’s layer in the upper bulb occurred normally (Fig. 2, R
and S). However, alterations in the shape and size of cells within
the hair shaft and IRS were evident in KO follicles. It was diffi-
cult to find good examples of medullated hair shafts in the KO.
Altogether, these data indicated that the sparsity seen in the KO
hair coat is rooted in structural abnormalities within the hairs
rather than in a reduction in follicle numbers.
 
Development and differentiation of hair 
follicles does not require Sgk3
 
To determine whether the loss of Sgk3 compromised hair follicle
morphogenesis or differentiation, we first conducted a histologi-
cal analysis of postnatal skin. Through P2, the morphology and
biochemistry of KO hair follicles were indistinguishable from
wild type (WT) by histology and immunofluorescence micros-
copy with markers that typified differentiation of the hair shaft
(AE13; stains hair keratins), IRS (AE15; stains trichohyalin
granules), and companion cell layer (K6; Fig. 3, A–H).
Figure 2. Sgk3 is required for normal hair coat production. Adult mice
(P36 and P411) have a sparse, uneven hair coat (A–D) and irregular hair
shafts when seen in profile (E and F). Whiskers are malformed (G and H).
Plucked hairs (I and J) lack normal guard, awl, or zigzag hairs. Scanning
EM (K and L) shows KO hairs to be irregular and thin with occasional mal-
formed cuticles (arrowheads). Sgk3-null plucked hairs are shorter than WT
hairs, with the exception of guard hairs (M). Histology of adult back skin
demonstrates that a sparse coat is not caused by the loss of hair follicles
(arrows; N–Q). Transmission EM (TEM) of P3 follicles verifies the presence
of all cell types in KO follicles (R and S), including the three layers of the
IRS. Note the normal keratinization of Henley’s layer of the IRS in the up-
per bulb (asterisks). HS, hair shaft; Ci, IRS cuticle; Hu, Huxley’s layer of
the IRS; He, Henley’s layer of the IRS; ORS, outer root sheath.
Figure 1. Targeting of the Sgk3 gene by homologous recombination.
(A) Schematic of WT mouse Sgk3 domain structure, gene locus, targeting
construct, and mutated Sgk3 allele. Exons 8 and 9 were replaced with
PGKneo, and diphtheria toxin A was used for negative selection. Indi-
cated are the antibody binding site, the 5  external probe A that was used
for Southern hybridization, predicted sizes of hybridizing fragments, and
primer pairs that were used for PCR. Short arrows represent the primers
that were used for PCR analysis of WT (a and b) or mutant (c and d) al-
leles. RV, EcoRV; Xb, XbaI; S, SmaI. (B) Southern hybridization analysis
(SB) of F2 offspring of intercrosses of Sgk3 mutant F1 mice. Tail genomic
DNA digested with XbaI was probed with external probe A; W, WT al-
lele; M, mutant allele. (C) Northern analysis (NB) of Sgk3 mRNA expres-
sion in total mRNA extracted from P5 skin. EtBr, ethidium bromide. (D)
Western immunoblot (WB) shows the presence of Sgk3 in cultured kerati-
nocytes. (E) Immunoblot of dispase-separated epidermis and dermis hair
follicle (HF) fractions shows Sgk3 (arrows) in the hair follicle fraction but
not in the interfollicular epidermal fraction and also demonstrates that
Sgk3 is expressed throughout the hair cycle in whole skin. Extra bands on
Western blots are a result of nonspecific signal. Actin, loading control. 
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A previous study on an independently generated 
 
Sgk3
 
-null
mouse attributed aberrations in the postnatal 
 
Sgk3
 
-null hair coat
to a loss of precortical Wnt signaling (McCormick et al., 2004).
Wnt signaling is required for hair keratin gene expression (van
Genderen et al., 1994; Zhou et al., 1995; DasGupta and Fuchs,
1999), and the normal hair keratin levels that are found in P2
 
Sgk3
 
-null follicles seemed inconsistent with impairment of this
pathway. To resolve this discrepancy, we mated 
 
Sgk3
 
-null mice
to a Wnt reporter mouse that expressed 
 
 
 
-galactosidase under
control of the T-cell factor (Tcf)/lymphoid enhancer factor (Lef)
optimal promoter, which contained multimerized Lef1/Tcf-bind-
ing sites (Tcf optimal promoter driving 
 
 
 
-galactosidase [TOP-
gal]; DasGupta and Fuchs, 1999). We determined canonical Wnt
activity by using two separate methods: in situ enzymatic detec-
tion of the 
 
 
 
-galactosidase substrate and immunoblot of whole
skin for total 
 
 
 
-galactosidase protein.
Both WT and KO P2 follicles displayed strong transgene
expression in the precortical cells that express the natural Wnt
target genes encoding hair keratins (Fig. 3, I and J). Even at P6,
when follicles were in full anagen, TOPgal activity was promi-
nent and of similar intensity in WT and KO follicles (Fig. 3, K
and L). Immunoblot analysis also revealed comparable levels of
TOPgal reporter expression (Fig. 3 M). Altogether, these find-
ings argue against an essential role for Sgk3 either in governing
hair follicle differentiation or in permitting Wnt signaling.
 
Sgk3-null follicles show abnormal
anagen morphology and fewer bulb cells
 
In the course of our Wnt-signaling studies, we observed
morphological differences in P6 follicles that were not de-
tected in P2 skin. Most notably, follicles lacking Sgk3
seemed to have arrested in early anagen. Closer inspection
revealed that as early as P3, 
 
Sgk3
 
-deficient hair follicles di-
verged from WT follicles. In contrast to normal follicles,
which were still growing downward into the subcutis be-
tween P3 and P6, KO hair bulbs arrested midway between
the epidermis and the base of the subcutis (Fig. 4, A–D).
Closer inspection revealed a distinctly smaller hair bulb;
rather than elongating to form the typical robust structure of
the normal P6 anagen phase bulb, KO P6 bulbs remained the
size of P2 bulbs (Fig. 4, E–H). Similarly, the associated
DPs, which were marked by alkaline phosphatase expres-
sion, remained small and round rather than becoming long
and thin, as is typical of WT P6 DPs (Fig. 4, E–H). These
defects were not merely a developmental delay in anagen.
Rather, 
 
Sgk3
 
 KO hair follicles never attained a normal ma-
ture anagen matrix.
We counted the number of epithelial nuclei that were vis-
ible per follicle within 10-
 
 
 
M sagittal skin sections. At P2,
when bulb sizes were approximately the same, the number of
matrix cells from the bottom of the bulb to the top of the DP
was similar between WT and KO follicles (Fig. 4 I). Between
P2 and P6, however, the matrix cell population increased dra-
matically in WT follicles, but hardly changed in KO follicles.
These data verified that the lack of expansion in the bulb size
of 
 
Sgk3
 
-null hair follicles was reflected in a corresponding fail-
ure to expand the matrix population.
 
Reduced proliferation and mildly 
increased apoptosis accounts for 
reduced cell number in Sgk3-null bulbs
 
A priori, a reduction in bulb cell number could be a result of an
increase in the rate at which cells are lost from the bulb, either
through cell death or differentiation. Alternatively, it could be a
resut of a decrease in the rate at which cells are gained in the
bulb through proliferation or migration from the outer root
sheath (ORS). To distinguish between these possibilities, we
evaluated rates of apoptosis and proliferation at P2 and P6.
Because Sgk3 was initially identified as a survival kinase
(Liu et al., 2000), one explanation for the reduced cell number
could be increased sensitivity to proapoptotic signals. Analysis
of apoptosis by activated caspase 3 detection in tissue sections
(see Fig. 6) and confirmed morphologically by transmission
EM (Fig. 4, J and K) revealed an increase in the number of ap-
optotic cells in KO P6 follicles. However, even though apopto-
sis was more frequent in 
 
Sgk3
 
-null follicles than in their WT
counterparts, many KO follicles had no apoptotic cells, and the
Figure 3. Hair follicle morphogenesis is normal in Sgk3-null mice until P2.
At P2, follicles have normal histology by hematoxylin and eosin (A and B),
including ORS, IRS, and hair shaft (HS) layers. Follicle number and density
is normal (C and D). Differentiation markers AE13 (hair keratins; hair shaft
cortex), AE15 (trichohyalin; IRS), and keratin 6 (K6; companion cell layer
[CCL]) are normal in KO follicles at P2 (E–H). Wnt pathway member Lef1
(lymphoid enhancer factor 1) is normal (E and F); mating Sgk3-null mice to
Wnt reporter TOPgal mice reveals normal intensity of reporter activity in
KO hair follicles at P2 and P6 (I–L). Arrows represent blue Xgal precipitate,
demonstrating activity of the TOPgal Wnt reporter. Immunoblot of whole
skin lysates at P2 confirms equal amounts of  -galactosidase (M). Mx, ma-
trix; DP, dermal papilla; Epi, epidermis; De, dermis; Pc, precortex; Mg,
melanin granules. DAPI, nuclear counterstain; Xgal,  -galactosidase enzy-
matic substrate. Bars (A, B, and E–H), 20  M; (C, D, and I–L) 100  M. 
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overall number of cells undergoing apoptosis was quantita-
tively too low to explain the large reduction in bulb cell num-
ber that was evident at P6 (Fig. 4 I).
Next, we measured proliferation in WT and 
 
Sgk3
 
-null
hair bulbs. After administering a 2-h pulse of BrdU, we quanti-
fied the number of labeled cells (Fig. 4, L–O). At P2, the num-
ber of S phase cells in the bulbs were similar, which is consis-
tent with the equivalent histology and cell number. By P6,
however, the number of proliferating cells in WT bulbs had in-
creased, whereas KO bulbs displayed fewer proliferating cells
than at P2. This difference resulted in a substantially reduced
number of dividing cells in KO bulbs at P6 when compared
with WT, which is on par with the decline in overall bulb cell
number (Fig. 4 I). The number of BrdU-positive cells in the
ORS was slightly reduced in P6 KO follicles, although the
measurement did not reach significance (unpublished data).
Based on these findings, the difference in bulb cell number ap-
pears to be largely attributable to a reduction in proliferation
with a small contribution from increased apoptotic death.
 
Fate mapping S phase cells suggests 
that the bulb defect results from 
inadequate recruitment or regeneration 
of progenitor cells
 
Fewer dividing cells in 
 
Sgk3
 
-null bulbs could result from either
slower progression through the cell cycle, a reduced number of
divisions before cell cycle exit, or a reduced supply of bulb
progenitor cells (Fig. 5 B). Slower progression through the cell
cycle would result in a bulb with equal or reduced cell number
and with a reduced rate of production of differentiated hair
shaft layers. On the other hand, premature exit from the cell cy-
cle, which is possibly associated with premature differentia-
tion, could explain the lower proliferation and also the reduced
cell number. To evaluate the rate of cell cycle exit and entry
into differentiation pathways, we pulsed pups with BrdU for
4 h and then chased for 12 or 20 h to monitor the fates of dividing
cells (Fig. 5 A). The cell cycle in the anagen matrix is known to
be 
 
 
 
18 h (Lehrer et al., 1998). By costaining for BrdU and dif-
ferentiation markers of the hair shaft, we measured the number
of dividing cells that progress to terminally differentiate versus
the number that remain in the lower germinative region of the
matrix. The data are compiled in Fig. 5 D.
The number of BrdU-positive matrix cells that pro-
gressed to terminally differentiate was markedly reduced in the
KO. However, the total number of matrix cells was also reduced
concomitantly, and, hence, the percentage of BrdU-labeled cells
that differentiated was comparable with the WT and 
 
Sgk3
 
 mu-
tant bulbs (Fig. 5, C and D). Because the number of differenti-
ated matrix cells did not increase in KO bulbs, the anagen bulb
defect could not be explained by premature exit from the cell
cycle with premature differentiation. As KO bulbs showed no
signs of accumulating undifferentiated cells between the BrdU-
positive germinative region and the differentiating compart-
ment (Fig. 5, C and D), early cell cycle exit without premature
differentiation also did not appear to be causative. Finally, be-
cause the reduced bulb proliferative number was proportional
to the reduced bulb cell number, the percentage of bulb cells
that were proliferative was unchanged (Fig. 5 D), suggesting
that slowed cell cycle does not cause the defect. Altogether,
these experiments indicate that reduction in the matrix cell pool
in 
 
Sgk3
 
-null follicles results from reduced recruitment or self
renewal of progenitor cells of the matrix and not from impaired
proliferation of the matrix cells themselves.
 
Sgk3-null hair follicles enter catagen 
earlier rather than later
 
One theory regarding the transition from anagen to catagen is
that the bulb exhausts its supply of transiently amplifying ma-
trix cells. If this model is correct, our findings would predict
that the 
 
Sgk3
 
-null mouse should enter catagen early. To test
this hypothesis, we analyzed the kinetics and biochemistry of
Figure 4. Anagen maturation is impaired in Sgk3-null hair follicles. His-
tology is similar at P2 (A and B) but by P6, Sgk3-null follicles are smaller
and fail to grow down to the bottom of the subcutis (C and D). At P6, the
shortened KO bulb has a smaller, rounded DP relative to the long, thin DP
of WT follicles (G and H). Apoptotic cells are seen in some KO follicle
bulbs (J and K); although many P6 bulbs show no apoptotic cells, some
have as many as six. Incorporation of BrdU in KO bulbs at P6 is reduced
relative to WT bulbs (L–O). Arrows represent examples of BrdU-positive
nuclei. (I) Quantification shows that total cell number is reduced in KO
bulbs at P6, apoptotic cell number is increased, and proliferation is mark-
edly decreased. Epi, epidermis; De, dermis; SubQ, subcutis; Mx, matrix;
Mg, melanin granules; TEM, transmission EM; AP, alkaline phosphatase.
Bars (A–D), 100  M; (E–H and L–O) 20  M; (J and K) 10  M. 
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this critical stage of the hair cycle in 
 
Sgk3
 
-null mice and their
WT counterparts. The results are compiled in Fig. 6.
In WT mice, the first anagen lasted from approximately
P2 through P14, and by P15, follicles had synchronously en-
tered catagen (Fig. 6, A–E). Although some variability is
known to exist among different mouse strains, our data were
in good agreement with previously reported analyses of nor-
mal mice (Muller-Rover et al., 2001). In striking contrast,
 
Sgk3
 
-null follicles displayed a catagen-like morphology as
early as P9, and by P12, most follicles were regressing (Fig. 6,
F–H). Remarkably, by P12, follicles in the upper back had al-
ready completed catagen and telogen and had actually reen-
tered anagen (Fig. 6, EE). By P15, most 
 
Sgk3
 
-null follicles
had already initiated the next hair cycle (Fig. 6 I). Reentry
into anagen did not begin in WT littermates before P20 (not
depicted). In P18 KO skin, histological signs of anagen were
seen in some follicles and catagen was seen in others, indicat-
ing a similar rapid transition from anagen to catagen in the
second hair cycle (Fig. 6 J).
Although the hair cycle phases are associated with histo-
logical differences, transitions from one hair cycle stage to an-
other are best evaluated by a combination of biochemistry and
histology. To unequivocally establish early entry into catagen
and to determine whether the anagen to catagen transition is
biochemically normal in 
 
Sgk3
 
-null follicles, we determined en-
dogenous alkaline phosphatase activity of DP cells (Muller-
Rover et al., 2001) and BrdU incorporation of matrix cells
throughout the hair cycle. This combinatorial method enabled
us to precisely track the hair cycle stages from P6 through P18.
Normal anagen is marked by robust BrdU incorporation
in the matrix and by characteristic DP morphology (Fig. 6, K–N);
during catagen, BrdU incorporation declines, and the DP be-
comes a round, small cluster of cells (Fig. 6 O). In 
 
Sgk3
 
-null
follicles, a dramatic reduction in BrdU incorporation in the
matrix with the characteristic catagen evolution of the DP con-
firmed that catagen was well underway by P9 (Fig. 6, P and Q).
Interestingly, despite premature onset, the morphology and
biochemistry of catagen appeared to be normal. Kinetics of the
transition through catagen into the first telogen and the follow-
ing anagen also seemed to be largely normal, proceeding over a
period of 
 
 
 
6 d (Fig. 6, compare M–O with P–R).
We also addressed whether the absence of Sgk3 altered the
rate of apoptosis during the hair cycle. A sensitive and reliable
method to capture this rapidly occurring process in hair follicles
is immunofluorescence microscopy with antibodies against acti-
vated caspase 3, which is a specific and direct consequence of
apoptotic machinery activation. Representative frames of these
data are shown in Fig. 6 (U–DD). Normal follicles only exhib-
ited anticaspase 3–labeled cells as they entered catagen, when a
burst of caspase 3 activity was detected in the bulb and epithelial
strand as it regressed upward. In 
 
Sgk3
 
-null follicles, anticaspase
3 labeling was also restricted largely to these sites and stages in
Figure 5. BrdU fate mapping distinguishes
between models for reduced bulb cell number
and proliferation. (A) Experimental design;
mice pulsed with BrdU at P4 were chased for
12 or 20 h. (B) Predicted outcomes for three
models. The percentage of Brdu  cells reflects
the percentage of total bulb cells that are
BrdU . The No. of BrdU /Diff /bulb re-
flects the cells per bulb that are positive for
BrdU and are above the boundary (dotted
lines) of differentiation marker expression. The
percentage pf BrdU /Diff  is the percentage
of BrdU  cells that are above the boundary
relative to the total. Distinguishing between an
intrinsic proliferative defect in matrix cells
(models 1 and 2) and a defect in the recruit-
ment or regeneration of matrix cells (model 3)
relies on the measurement of the percentage
of BrdU  cells. (C) Representative sections
demonstrate movement of BrdU-labeled cells.
Note that the total number of BrdU-positive
cells at 20 h is double the number at 4 h,
which is consistent with the expected division
after S phase. This confirms that ongoing la-
beling beyond 4 h does not occur. Dotted
lines mark the lower limit of hair keratin expres-
sion. HS, hair shaft; Mx, matrix. Bars, 20  m.
(D) Quantification reveals that the most likely
explanation for reduced cell number is im-
paired recruitment or regeneration of progeni-
tors. Error bars represent SEM.SGK3 MAINTAINS HAIR FOLLICLE PROGENITOR CELLS • ALONSO ET AL. 565
the hair cycle (Fig. 6 DD). We did see occasional apoptotic cells
in KO anagen bulbs, but, as a result of the absence of morpho-
logical criteria to distinguish anagen VI from catagen I, we can-
not exclude the possibility that these events represent very early
catagen. The differences that were seen in the timing at which
anticaspase 3 labeling was detected correlated well with the pre-
mature entry of Sgk3-null follicles into catagen. Additionally,
the mixture of anagen and catagen phase follicles that was noted
previously in P18 Sgk3-null skin was further confirmed by anti-
caspase 3 staining (Fig. 6 DD). Although unprecedented for
such an early age, this asynchrony in cycling of the Sgk3-null
hair coat could reflect the progressive asynchrony that normally
occurs with successive hair cycles in WT mice.
Fig. 6 (EE–GG) provides quantification of all of the data
from the experiments that are illustrated in Fig. 6. These data
graphically illustrate the defect in Sgk3-null follicles as a mark-
edly shortened anagen phase of the hair cycle. Altogether, our
data suggest that in the absence of Sgk3, reduced maintenance
or supply of matrix progenitor cells results in impaired matura-
tion of anagen followed by precocious entry into catagen.
Figure 6. Hair follicles lacking Sgk3 enter catagen prematurely. Histology shows the onset of catagen in WT skin at P15 and in KO skin at P9 (A–J).
(EE) Quantification of hair cycle stage based on DP morphology that was visualized by alkaline phosphatase (Muller-Rover et al., 2001). Anagen (alI
stages); early catagen (catagen I–III); late catagen (IV–VIII). Note that Sgk3-null follicles enter catagen prematurely; by P15, they have entered the second
anagen. (K–T) BrdU staining and DP morphology suggest that KO catagen traverses normal stages. Arrows represent BrdU-positive nuclei. (O) Straight dot-
ted line demarcates the bottom of the permanent portion of the hair follicle. (FF) Quantification of BrdU incorporation confirms the appropriate decline in
proliferation as KO follicles enter catagen. (U–DD) Staining for activated caspase 3 shows that apoptosis in Sgk3-null follicles increases normally during
catagen, excluding massive apoptosis as a mechanism to explain reduced bulb cell number or premature catagen. (Y) Plus signs indicate autofluorescence
of the hair shaft ( ) and differentiated epidermis (  ). Arrowheads, caspase ( ) cells. (GG) Quantification of apoptosis confirms the increased number
of apoptotic cells in KO skin. Mx, matrix; Ana, anagen; Cat, catagen; Mg, melanin granules; DP, dermal papilla; Cb, Club hair. Error bars represent SEM.
Bars (A–J), 100  M; (K–DD) 20  M.JCB • VOLUME 170 • NUMBER 4 • 2005 566
Sgk3-null keratinocytes display 
increased downstream growth factor 
signaling in response to IGF-1
Several tyrosine kinase receptor growth factors have been im-
plicated in the anagen–catagen transition, including EGF, IGF-1,
and FGF5 (Fig. 7 A; Philpott et al., 1994; Murillas et al., 1995;
Hansen et al., 1997; Sundberg et al., 1997). Interestingly, the
morphological and hair cycle defects that were observed in
Sgk3-null follicles were similar to those described upon injec-
tion of EGF into mice and sheep (Moore et al., 1981, 1982;
Hollis et al., 1983; Hollis and Chapman, 1987).
To evaluate where downstream growth factor signaling
occurs in the hair follicle, we performed immunofluorescence
for phosphorylated (i.e., active) forms of ERK 1/2 and Akt.
The phospho-ERK antibody revealed specific staining at P6 in
the interfollicular epidermis without clear localization in the
hair follicle (unpublished data). However, immunofluorescence
for phospho-Akt revealed specific staining in K5-positive cells
that were located in the upper ORS (infundibulum) above the
stem cell compartment and in the ORS below the stem cell
compartment (Fig. 7, B–E). Throughout the hair cycle, phos-
pho-Akt patterns were similar from early anagen (P2) through
late catagen (P18) without significant alteration in distribution
or intensity (unpublished data). As previously noted (Hansen et
al., 1997), anti-EGF receptor (R) immunofluorescence showed
labeling in the ORS, interfollicular epidermis, and matrix (Fig.
7, F–I); this staining persisted into catagen (unpublished data).
Intriguingly, EGFR and phospho-Akt labeling were present in
a region of the anagen and catagen phase ORS where matrix
cell progenitors are thought to reside (Taylor et al., 2000;
Oshima et al., 2001). Based on these data and the observation
that the Sgk3 loss-of-function phenotype resembles EGF gain-
of-function results, we wondered whether Sgk3 might modu-
late downstream growth factor signaling.
To test this possibility, we took advantage of the ability to
culture primary keratinocytes from newborn mouse skin (i.e.,
at an age that preceded the defects seen in Sgk3-null animals).
We determined the response of WT and KO keratinocytes
to two key growth factors, EGF and IGF-1, by measuring the
activation of two principle downstream pathways, Ras–Raf–
MEK–MAPK (ERK 1/2) and PI3K–PDK1–Akt.
Within minutes after EGF addition, both WT and KO
keratinocytes displayed a rapid increase in activated (phos-
phorylated) ERK 1/2 (Fig. 8 A). This response appeared to be
comparable in magnitude and kinetics irrespective of the sta-
tus of Sgk3. The kinetics and levels of Akt activation after
EGF addition were also comparable in WT and KO cells (Fig.
8 A). Thus, the loss of Sgk3 in keratinocytes did not appear to
influence EGF-mediated activation of either the MAPK or
Akt pathways.
Surprisingly, when the experiments were repeated using
IGF-1 rather than EGF, the outcomes were different, as the re-
sults were dependent on the presence of Sgk3. In the absence of
Sgk3, both MAPK and Akt were activated to higher levels than
in WT keratinocytes (Fig. 8 B). Antibodies to total ERK 1/2
and Akt showed that these differences were not caused by
changes in the overall levels of ERK 1/2 or Akt proteins but
rather were selective for the phosphorylated forms (Fig. 8 B).
These data suggest that Sgk3 reduces the downstream response
of keratinocytes to IGF-1.
The molecular brake exerted by Sgk3 appeared to be
one that impacted equivalently on both arms of the signaling
pathway. A priori, this could be a reflection of an effect on a
shared member of these corridors, such as the tyrosine kinase
receptor itself. However, we noticed that the kinetics of ERK
1/2 activation by IGF-1 were delayed relative not only to Akt
activation but also to EGF-mediated activation of ERK 1/2
(Fig. 8, A and B). This observation led us to wonder whether
ERK 1/2 and Akt activation by IGF-1 might be in a linear
pathway, which would place them both downstream of PI3K
in primary keratinocytes.
To test this possibility, we pretreated keratinocytes with a
PI3K-specific dose of wortmannin and stimulated with IGF-1
or EGF. As shown in Fig. 8 C, wortmannin effectively elimi-
nated the IGF-1 activation of ERK 1/2 but had no effect on
EGF activation of ERK 1/2. As expected, wortmannin blocked
Akt activation in both WT and KO keratinocytes in response to
both IGF-1 and EGF (Fig. 8 C). These findings demonstrate
that the ability of IGF-1 to stimulate ERK 1/2 activation is
dependent on PI3K activity in primary keratinocytes. Also,
Figure 7. Growth factor signaling elements are present in the hair follicle.
(A) Schematic depicting EGF and IGF-1 pathways and known effects on
the anagen to catagen transition. Note the strong evidence that EGF and
EGFR promote catagen, which are consistent with the observation that
Pten, which is inhibitory to PI3K, may promote anagen. (B–I) Localization
of growth factor signaling in the hair follicle. Phospho-Akt is present
strongly in the upper ORS, colocalizing with K5, in both WT and KO skin
at P6 (B–E). EGFR is expressed in the ORS, colocalizing with K5, and in
the interfollicular epidermis and hair bulb (F–I). Arrowheads indicate co-
localization with K5 in the ORS.SGK3 MAINTAINS HAIR FOLLICLE PROGENITOR CELLS • ALONSO ET AL. 567
enhanced ERK 1/2 and Akt activation after IGF-1 may both re-
sult from increased PI3K signaling in Sgk3-null keratinocytes.
Finally, it was important to determine whether PI3K de-
pendence on ERK 1/2 activation by IGF-1 resulted from an
interdependence of the MAPK and PI3K pathways or, alter-
natively, resulted from unidirectional activation of MAPK
through PI3K. To distinguish between these two possibilities,
we pretreated keratinocytes with the specific MEK inhibitor
444937 and assayed for activation of ERK 1/2 and Akt. In all
cases, ERK 1/2 activation was quantitatively blocked by
MEK inhibition, which did not impair Akt activation (Fig. 7 D).
These data demonstrate that ERK 1/2 activation is dependent
on both the MEK kinase and PI3K in response to IGF-1 in
keratinocytes but that Akt activation is independent of MEK
activation.
Discussion
Our findings uncover a novel role for a member of the Akt/
Sgk family of serine-threonine kinases in maintaining the
pool of hair progenitor cells and in regulating the transition
from life to death at the end of the growth phase of the hair
cycle. We discovered that the loss of function of Sgk3 re-
duces the supply of transit-amplifying progenitor cells and
causes premature entry into the apoptotic regression phase of
the hair cycle. Finally, we placed Sgk3 within the framework
of tyrosine kinase growth factor receptor signaling, discover-
ing a unique ability of Sgk3 to temper the effects of IGF-1–
induced PI3K signaling.
Tyrosine kinase receptor activation and 
the anagen to catagen transition
The relation between growth factor signaling and the anagen–
catagen transition has remained poorly understood for decades.
Mice lacking FGF5 enter catagen late, suggesting an important
role for FGF receptor signaling in the regulation of this transi-
tion (Hebert et al., 1994; Sundberg et al., 1997). This said, it
has been suggested that FGF5, which is expressed in the ORS,
may act on DP cells (Rosenquist and Martin, 1996), providing
the potential for this interesting factor to regulate catagen
through mesenchymal–epithelial interactions.
In the early 1980s, experiments showed that EGF pro-
motes early transition from anagen to catagen, which is associ-
ated with decreased proliferation and increased apoptosis (Hol-
lis et al., 1983; Hollis and Chapman, 1987). Genetic loss of
function of the EGF receptor in mice causes premature differen-
tiation in the hair bulb along with delayed catagen (Murillas et
al., 1995; Hansen et al., 1997). Because excessive EGF signal-
ing promotes catagen and the loss of EGFR promotes premature
differentiation, it seems that the dose of EGF signaling in nor-
mal anagen is carefully balanced, supporting the relevance of
downstream regulators that modulate pathway strength.
IGF-1 has also been implicated in hair cycle regulation,
although the evidence is less strong than for EGF. It is curious
that in keratinocytes, we see a difference with IGF-1 treatment
but not with EGF treatment; this may be related to contextual
differences in cultured keratinocytes as compared with growth
factor responsive cells in living skin. IGF-1 is expressed by the
DP, and IGF-1R is found in the matrix (for review see Su et al.,
1999a). Genetic models of IGF-1 function in skin include
transgenic mice overexpressing IGF-1 (Bol et al., 1997; Su et
al., 1999b; Wilker et al., 1999; DiGiovanni et al., 2000) as well
as the IGF-1R KO (Liu et al., 1993), but the hair cycle has not
been evaluated in any of these animals. Human hair follicles in
organ culture are reported to enter a catagen-like state upon
withdrawal of IGF-1 from the culture medium (Philpott et al.,
1994). It is possible that IGF-1 produced by the DP might sig-
nal to adjacent matrix cells expressing IGF-1R, regulating the
choice between proliferation, differentiation, and apoptosis.
Downstream events of receptor 
activation and the anagen to
catagen transition
Downstream of the growth factor ligand, less is understood
about receptor tyrosine kinase signaling in the anagen to catagen
transition. Our findings predict a role for PI3K in the onset of
catagen. Consistent with this idea, skin epithelium lacking the
PI3K inhibitor phosphatase and tensin homologue on chromo-
some 10 (Pten) shows decreased skin thickness at P10, and it has
been suggested that follicles might enter catagen early (Suzuki et
al., 2003). Because loss of Pten should result in excessive activa-
tion of PI3K (Sulis and Parsons, 2003), early catagen in follicles
lacking Pten is consistent with PI3K exerting procatagen effects.
Akt1 and Akt2 double KO mice have delayed hair follicle
development, but the hair cycle was not evaluated (Peng et al.,
2003). Our findings that Sgk3 KO mice have a hair cycle defect
in the presence of Akt1 and Akt2 suggest that even if these Akts
Figure 8. Growth factor signaling is abnormal in Sgk3-null keratinocytes.
(A) Treating WT and KO primary keratinocytes with 10 ng/ml EGF re-
veals normal kinetics of the activation of ERK 1/2 and Akt. (B) In response
to 50 ng/ml IGF-1, Sgk3-null keratinocytes exhibit increased activation of
ERK 1/2 and Akt. (C) In primary keratinocytes, IGF-1–mediated activation
of ERK 1/2 is dependent on PI3K activation, whereas EGF-mediated ERK
activation proceeds independently of PI3K. Cells were pretreated with
100 nM wortmannin for 30 min before stimulation. (D) PI3K-dependent
IGF-1 activation of ERK does not indicate codependence of PI3K and ERK
pathways; phosphorylation of Akt is unaffected by treatment with MEK in-
hibitor 444937. Cells were pretreated with 1  M 444937 for 30 min
before stimulation. Antibodies are against phosphorylated (activated) or
total ERK 1/2 or AKT 1–3 proteins.JCB • VOLUME 170 • NUMBER 4 • 2005 568
function in regulating the hair cycle, their effects are likely to be
distinct from those of Sgk3. The presence of activated PI3K in
the ORS, combined with our findings of increased PI3K sig-
naling in Sgk3-null keratinocytes and an inadequate supply of
matrix precursors in KO follicles, raises the interesting, unan-
swered questions of whether ORS progeny supply cells to the
bulb and, if so, whether PI3K might regulate this process.
Our studies in culture reveal that in the absence of Sgk3,
IGF-1 signaling through PI3K is more active, implying that
Sgk3 causes feedback inhibition on PI3K signaling in kerati-
nocytes. Because Sgk3 contains a Phox domain, which targets it
to the early endosome, Sgk3 might modulate tyrosine kinase re-
ceptor signaling complexes as they are activated and internal-
ized from the plasma membrane. Recent studies in other cell
types have shown that Phox domain targeting to the early endo-
some is required for Sgk3 activation by both IGF-1 and EGF
(Virbasius et al., 2001; Xu et al., 2001). Furthermore, endo-
somes containing Sgk3 colabel with internalized EGF at 5 and
15 min after cells are treated with labeled EGF (Xu et al., 2001).
Finally, the role of Sgk3 in maintaining matrix progeni-
tors may not be its only role in the hair follicle given the poor
coat quality. Because proliferation is required to produce hair
shaft and IRS layers, reduced proliferation and early termina-
tion of the growth phase can readily explain the reduced hair
shaft diameter and length. However, disorganization of the dif-
ferentiating layers, although possibly a reflection of continued
rapid differentiation in the absence of an adequate supply of
cells, may invoke an additional role for Sgk3 that is not identi-
fied in these studies.
We have uncovered Sgk3 as a new player in the anagen
to catagen transition. Our results provide insight into how the
transiently amplifying pool of matrix cells is maintained during
the growth phase of the hair cycle, shedding light on previously
unexplained observations regarding the effects of EGF and
Pten on the hair cycle. The data suggest a model in which
maintenance of the transiently amplifying cells is achieved by
Sgk3 and possibly Pten, which act either together or separately
to reduce the effects of PI3K signaling. Counterbalancing these
effects are positive growth factor signals, which elevate PI3K
signaling and push progenitor cell fate away from matrix main-
tenance and toward catagen. This work advances current
understanding of how growth factor signaling regulates the
anagen to catagen transition and lays the groundwork for future
studies in this arena.
Materials and methods
Generation of mice lacking Sgk3
E14K ES cells from 129/Ola mice were maintained on mitomycin C–treated
mouse embryonic fibroblasts in DME supplemented with leukemia inhibi-
tory factor, 15% heat-inactivated FCS (Hyclone), L-glutamine, and  -mer-
captoethanol. A 129J mouse bacterial artificial chromosome genomic li-
brary was screened with a murine Sgk3 partial cDNA probe. Restriction
mapping and sequencing of subcloned fragments revealed that the murine
Sgk3 gene contains 16 coding exons. The targeting vector replaced ex-
ons 8 and 9, encoding a critical part of the kinase domain, and the neo-
mycin resistance gene was under control of the phosphoglycerate kinase
(PGK) promoter (PGK-neo); stop codons were introduced downstream of
the splice acceptor site of exon 8. The diphtheria toxin A gene allowed for
negative selection. The targeting vector was linearized with NotI and was
electroporated into ES cells (0.34 kV and 250  F; Gene Pulser; Bio-Rad
Laboratories). 768 G418–resistant ES cell clones were screened by PCR
for homologous recombination; positive clones were confirmed by Southern
blotting using external probe A (Fig. 1 A). Nine correctly targeted clones
were identified; three were injected into C57BL/6J blastocysts, and two
independent Sgk3 mutant mouse strains were established.
Genotypes of mutant mice were determined by PCR and were con-
firmed by Southern blotting of genomic DNA from tail biopsies using an
external probe. Primers a and b detected the WT allele; primers c and
d, which are specific for neo, detected the mutant allele. The primer
sequences are listed as follows: primer a, 5 -ATTTTCCATCCAGTTTC-
CGTTTT -3 ; primer b, 5 -CACAGCCTCGCTTCAGTATTTT-3 ; primer c, 5 -
GTAGTGGGGCTGTGGTGAAATAAA-3 ; and primer d, 5 -CGCCTTC-
TATCGCCTTGAC-3 . For Northern analysis, samples were prepared from
P5 whole skin using Trizol; 18  g of total RNA was run on a formalde-
hyde gel in 1  MOPS, transferred to Zeta-Probe GT membrane (Bio-Rad
Laboratories), and probed using ExpressHyb (BD Biosciences). For immu-
noblot sample preparation, keratinocytes were lysed in NP-40–radioimmu-
noprecipitation assay (RIPA; 50 mM Tris, pH 7.4, 150 mM NaCl, 0.5%
NP-40, and 5 mM EDTA, pH 8.0). Skin fractions were obtained by dis-
pase (Roche) treatment for 30 min at 37 C; fractions that were frozen in
liquid nitrogen were smashed using a tissue smasher, resuspended in NP-
40–RIPA, sonicated 3   20 s, spun 20 min at maximum in a tabletop cen-
trifuge, and quantified using a Bradford-based assay. Membranes were
probed using an antibody generated against the NH2-terminal Phox do-
main (gift from Z. Songyang, Baylor College of Medicine, Houston, TX).
Microscopy, digital photography, and image processing
Gross images were obtained using a digital camera (model C-5060;
Olympus) or a dissection scope (model MZFLIII; Leica) equipped with a
camera (Axiocam; Carl Zeiss MicroImaging, Inc.) driven by Axiovision
(Carl Zeiss MicroImaging, Inc.). Light and fluorescent microscopy images
were obtained using a microscope (Axioskop; Carl Zeiss MicroImaging,
Inc.) equipped with 40  plan-Neofluar 1.3 (Immersol 518F oil), 20 
plan-Neofluar 0.5 (air), and 10  plan-Apochromat 0.45 (air) objectives
(all from Carl Zeiss MicroImaging, Inc.) and were captured using a cam-
era (Spot RT; Diagnostic Instruments) driven by Metamorph software
(Molecular Devices). Scanning EM images were obtained using a field
emission scanning electron microscope (model 1550; LEO Electron
Microscopy, Inc.), and transmission EM images were taken with a trans-
mission electron microscope (Tecnai G2-12; FEI) equipped with a digital
camera (model XR60; Advanced Microscopy Techniques, Corp.).
Tissue histology, immunofluorescence, and EM
Skin was frozen in optimal cutting temperature compound (VWR), and
10- M sections were cut. For alkaline phosphatase, sections were fixed in
4% PFA for 10 min at RT, reacted with BCIP/nitroblue tetrazolium in 100
mM Tris, pH 9.5, 100 mM NaCl, 50 mM MgCl2, and counterstained with
nuclear fast red (Vector Laboratories). For Xgal, sections were fixed for
2 min in 0.5% glutaraldehyde and reacted in 100 mM Na phosphate, pH
7.3, 1.3 mM MgCl2, 3 mM K3Fe(CN)6, 3 mM K4Fe(CN)6, and 1 mM Xgal
(Invitrogen). For immunofluorescence, sections were fixed 10 min in 4%
PFA. For mouse mAbs, we used the MOM basic kit (Vector Laboratories);
for all other antibodies, we blocked 1–4 h (2.5% normal goat serum,
2.5% normal donkey serum, 1% BSA, and 0.1% Triton X-100), incubated
with primary antibody overnight at 4 C in block, fluorescence conjugated
secondary antibodies (Jackson ImmunoResearch Laboratories) for 40 min
at RT in block, and counterstained with DAPI. For immunohistochemistry,
secondary antibodies were HRP conjugated; HRP substrate was Vector
Nova-Red (Vector Laboratories), and counterstain was hematoxylin. Anti-
bodies that were used are listed as follows: AE13 (1:50; gift from T.T. Sun,
New York University, New York, NY), AE15 (1:20; gift from T.T. Sun),
Lef1 (1:300; lab generated), keratin 6 (1:200; lab generated), BrdU
(1:500; Abcam), activated caspase 3 (1:1,000; R&D Systems), phospho-
Akt 1–3 (1:100; Cell Signaling), and EGFR (1:100; Upstate Biotechnology).
For scanning EM, samples were fixed in 2% glutaraldehyde, 4% PFA, and
2 mM CaCl2 in 0.05 M sodium cacodylate buffer, pH 7.2, at RT for  1 h,
dehydrated, critical-point dried, mounted, and sputter coated with gold
palladium. For transmission EM, samples were fixed as described for
scanning EM, postfixed in 1% osmium tetroxide, and processed for Epon
embedding; ultrathin sections (60–70 nm) were counterstained with uranyl
acetate and lead citrate.
Quantification of cell number, apoptosis, and proliferation
For cell number, sections were stained with hematoxylin; 20 consecutive
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counted from the bottom of the bulb to the top of the DP. For apoptosis,
sections were stained for activated caspase 3 and scored for the number
of bulbs present and number of cells that were positive for caspase per
bulb. For proliferation, mice were injected with 50  g/g BrdU (Sigma-
Aldrich) subcutaneous exactly 2 h before killing. Staining was performed
as described for immunofluorescence with an additional 30-min incuba-
tion in 1 N HCl at 37 C after fixation. 50 consecutive bulbs were counted
for the number of BrdU ( ) nuclei. All statistical analysis was performed
using Prism (GraphPad Software).
BrdU fate mapping of bulb cells
Mice injected with a single dose of 50  g/g BrdU at P4 were killed at 4,
12, or 20 h. Sections were stained with AE13, BrdU, and DAPI. For each
of three experiments, 10 bulbs per set were counted for total bulb cell num-
ber, BrdU ( ) cells below the line of AE13 differentiation (defined as the
lowest cell stained for AE13), and BrdU ( ) cells above the line of differen-
tiation. For counts above the level of differentiation, BrdU ( ) cells external
to, within, and internal to the AE13-positive cells were pooled such that
counts include IRS, hair shaft, and medulla cells; ORS cells were excluded.
Keratinocyte culture and growth factor experiments
Keratinocytes that were isolated by floating newborn skin on dispase
(Roche) overnight at 4 C, 0.1% trypsin (GIBCO BRL), and 40  M filtration
(BD Falcon) were grown in E medium (Rheinwald and Green, 1977) con-
taining 0.05 mM calcium and 15% FBS. Subconfluent cells that were
starved 16–24 h in E medium lacking serum were treated with 50 ng/ml
IGF-1 (Sigma-Aldrich), 10 ng/ml EGF (R&D Systems), 100 nM wortman-
nin (Sigma-Aldrich), and/or 1  M MEK inhibitor 444937 (Calbiochem).
Lysates were collected on ice in NP-40–RIPA with protease inhibitors. Anti-
bodies for Western blotting included phospho-MAPK (1:2,000; Sigma-
Aldrich), total MAPK, phospho-Akt (Ser473; binds Akt 1–3), and total Akt
(binds Akt 1–3; all 1:1,000; Cell Signaling).
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